Evidence used
- No CISA KEV confirmation is currently recorded.
- EPSS is 0.48% for the current model date.
BlackTreeCVE IntelligenceRed Hat · Red Hat build of Keycloak 26.4
Official source article: Red Hat RHSA-2026:68276 ↗. Check the applicable product and release in the original source.
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Structured product status and remediation from the issuing vendor. Product-state explanations are always visible; large lists can be searched or downloaded.
The vendor explicitly identifies these products or versions as containing the fix.
Medium technical severity with no CISA KEV confirmation; remediate through the normal risk-based patch cycle unless local exposure raises the priority.
Patch availableA flaw was found in the key provider component of the keycloak-services library, which is the core engine for the Red Hat Build of Keycloak. The issue occurs because a previous fix for path probing was incomplete, allowing a realm administrator to still submit arbitrary filesystem paths as keystore parameters. This can be used to determine the existence and readability of files on the server, potentially exposing sensitive system information.
A flaw was found in the key provider component of the keycloak-services library, which is the core engine for the Red Hat Build of Keycloak. The issue occurs because a previous fix for path probing was incomplete, allowing a realm administrator to still submit arbitrary filesystem paths as keystore parameters. This can be used to determine the existence and readability of files on the server, potentially exposing sensitive system information.
Attacker-controlled path data is not constrained to the intended directory before the application accesses a file.
An attacker operating through a network path may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
A flaw was found in the key provider component of the keycloak-services library, which is the core engine for the Red Hat Build of Keycloak. The issue occurs because a previous fix for path probing was incomplete, allowing a realm administrator to still submit arbitrary filesystem paths as keystore parameters. This can be used to determine the existence and readability of files on the server, potentially exposing sensitive system information.
Attacker-controlled path data is not constrained to the intended directory before the application accesses a file.
An attacker operating through a network path may attempt exploitation with elevated privileges. If successful, the issue may cause the confidentiality, integrity or availability impact described by the vendor.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
No exploit-tagged reference or CISA SSVC proof-of-concept state is currently recorded. Research may still exist outside the structured feeds.
CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'). The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:N/A:NCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 9 Sept 2026 · Last source change 16 Sept 2026, 18:34 UTC · CWE-22 · Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
Missing structured fields: affected versions. Missing data is not evidence of low risk; review the primary advisory.